PTPRC and neoplasm: There was also a significant decrease in CD3e+PD-1+, CD8a+PD-1+, and CD4+PD-1+ T cells, as well as CD45+ cells in post- versus pre-ICI tumor samples (P < .05, Data Supplement, Fig S16).